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Abstract
Background: Propionibacterium acnes and Staphylococcus epidermidis live in close proximity on human skin, and
both bacterial species can be isolated from normal and acne vulgaris-affected skin sites. The antagonistic
interactions between the two species are poorly understood, as well as the potential significance of bacterial
interferences for the skin microbiota. Here, we performed simultaneous antagonism assays to detect inhibitory
activities between multiple isolates of the two species. Selected strains were sequenced to identify the genomic basis
of their antimicrobial phenotypes.
Results: First, we screened 77 P. acnes strains isolated from healthy and acne-affected skin, and representing
all known phylogenetic clades (I, II, and III), for their antimicrobial activities against 12 S. epidermidis isolates.
One particular phylogroup (I-2) exhibited a higher antimicrobial activity than other P. acnes phylogroups. All
genomes of type I-2 strains carry an island encoding the biosynthesis of a thiopeptide with possible antimicrobial
activity against S. epidermidis.
Second, 20 S. epidermidis isolates were examined for inhibitory activity against 25 P. acnes strains. The majority of S.
epidermidis strains were able to inhibit P. acnes. Genomes of S. epidermidis strains with strong, medium and
no inhibitory activities against P. acnes were sequenced. Genome comparison underlined the diversity of S.
epidermidis and detected multiple clade- or strain-specific mobile genetic elements encoding a variety of
functions important in antibiotic and stress resistance, biofilm formation and interbacterial competition,
including bacteriocins such as epidermin. One isolate with an extraordinary antimicrobial activity against P.
acnes harbors a functional ESAT-6 secretion system that might be involved in the antimicrobial activity against
P. acnes via the secretion of polymorphic toxins.
Conclusions: Taken together, our study suggests that interspecies interactions could potentially jeopardize
balances in the skin microbiota. In particular, S. epidermidis strains possess an arsenal of different mechanisms
to inhibit P. acnes. However, if such interactions are relevant in skin disorders such as acne vulgaris remains
questionable, since no difference in the antimicrobial activity against, or the sensitivity towards S. epidermidis
could be detected between health- and acne-associated strains of P. acnes.
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Background
The microbiota of human skin is unique and complex,
and is composed of a mixture of different groups of
microorganisms: anaerobic, aerotolerant bacteria, such
as propionibacteria; facultative anaerobic bacteria, such
as staphylococci; fungi, such as Malassezia spp., and
bacteriophages and viruses.[1, 2] According to both
culture-based studies and metagenomic investigations,
propionibacteria dominate in sebaceous sites and
staphylococci and corynebacteria preferentially colonize
moist areas [1–3]. However, different genera and species
live in close proximity, in particular the two predomin-
ant skin species Staphylococcus epidermidis and Propi-
onibacterium acnes. S. epidermidis colonizes various
areas of the skin and is considered to be a skin com-
mensal, but it can act as an opportunistic pathogen
when it breaches the skin surface and enters the blood-
stream [4, 5]. P. acnes resides mainly in the piloseba-
ceous skin follicles; despite being a commensal with
potential health-beneficial effects [6], evidence exists
that the bacterium can also be an opportunistic patho-
gen, e.g., in postoperative infections [7, 8]. The inter-
action between S. epidermidis and P. acnes and its
relevance for skin health and disease of the host is
largely unknown. This microbial interplay, for instance
mediated through molecules involved in intercellular
competition or communication, may have an impact on
the fine balance of the skin ecosystem. A disturbed bal-
ance (dysbiosis) can impact skin health and might initi-
ate or support the events that lead to skin disorders [9].
One of such disorders is acne vulgaris, a multifactorial
disease of pilosebaceous units of the skin that affects
adolescents [10]. Microorganisms have been associated
with this disease, in particular P. acnes, and it has been
reported that S. epidermidis and P. acnes can be isolated
together from acne-affected sebaceous follicles [11].
Both species, P. acnes and S. epidermidis, are multi-
phyletic; P. acnes exhibits very limited strain- and
cluster-level variation, whereas S. epidermidis strains and
clades are more heterogeneous [12, 13]. Phylogenetic
analyses can separate the P. acnes population into the
clades I, II and III, which can be further subdivided into
subclades and clonal complexes [12, 14–16]. Recently,
the potential importance of P. acnes strain variation has
been highlighted: certain lineages of P. acnes, in particu-
lar those of the I-1a cluster, are associated with acne,
while other lineages are associated with healthy skin or
deep tissue infections [12, 16, 17].
Here, we investigated the antagonistic interactions
between P. acnes and S. epidermidis, including strains of
both species that have been isolated from healthy and
acne-affected skin. Our study revealed various levels of
antagonism between S. epidermidis and P. acnes and
highlighted the importance of strain-level variation.
Genome sequencing of inhibitory S. epidermidis strains
revealed an arsenal of fitness and competition functions
encoded in the accessory genome. One potent strain
possessed the epidermin biosynthesis cluster, and an-
other strain harbours a functional type VII secretion
system that might confer antimicrobial activity.
Results
Selection of bacterial strains and principal methodology
Bacterial isolates, 77 and 24 strains for P. acnes and S.
epidermidis, respectively, were previously obtained by
swab sampling from human skin of acne patients and
healthy individuals [12]. Some additional strains were
obtained from the CCUG strain collection (Additional
file 1 and Additional file 2). All P. acnes strains were
phylogenetically analysed by multi-locus-sequence typ-
ing (MLST), using the scheme of Lomholt and Kilian
[12]. The P. acnes isolates covered all major clades (I, II,
III) and all sequence types assigned by Lomholt and
Kilian [12].
Simultaneous antagonism assays were carried out. In
the first set of experiments, the antimicrobial activity of
P. acnes against S. epidermidis was investigated: strains
of S. epidermidis were suspended on the agar surface,
thus representing the indicator strains, and P. acnes was
added as stab culture. In the second set of experiments,
in order to assess the antimicrobial activity of S. epider-
midis, P. acnes isolates were used as indicator strains in
a similar set-up.
P. acnes strains from the phylogroup I-2 displayed
increased antimicrobial activity against S. epidermidis
A total of 77 P. acnes strains were screened for their
antimicrobial activity against 12 S. epidermidis strains. A
positive inhibitory effect was defined as a zone of inhib-
ition around the P. acnes stab culture of at least 2 mm.
The P. acnes strains displayed varying degrees of anti-
microbial activity against S. epidermidis. Among the P.
acnes strains are potent inhibitors of S. epidermidis, such
as strains 2.3.A1 (I-2, ST35) and 27.1.A1 (I-2, ST38) that
inhibited 9 out of 12 S. epidermidis strains. Other strains
had little inhibitory effect, such as strains 5.1.R1 (II,
ST52), CCUG33951 (II, 48) and CCUG50480 (I-1a, ST6)
that inhibited only 1 out of 12 S. epidermidis strains
(Additional file 3).
One phylogroup, I-2, represented by 14 strains, dis-
played a significantly higher frequency of antimicrobial
activity against S. epidermidis than the other phy-
logroups (I-1a, I-1b, III and II). P. acnes I-2 strains
inhibited on average 61 % of the tested S. epidermidis
strains, whereas strains of the other P. acnes types inhib-
ited on average only 29 % of the tested S. epidermidis
strains (Table 1). The reason for the broader antimicro-
bial activity of I-2 strains, i.e., inhibiting a higher
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proportion of the tested S. epidermidis strains, is likely
to be found in the genomic regions that are specific for
I-2 strains. On the accessory genome of type I-2 strains
a genomic island is located that encodes a thiopeptide
similar or identical to berninamycin A of Streptomyces
bernensis [18, 19].
No difference in prevalence and intensity was noted in
the antimicrobial activity of P. acnes strains isolated
from normal and acne-affected skin (Table 2). Among
the I-1a strains, isolates from acne patients were not dis-
tinct in their anti-S. epidermidis activity from isolates
obtained from healthy skin. This suggests that a particu-
lar antimicrobial activity of P. acnes against S. epidermi-
dis does not play a role in the acne-associated
microbiota.
Strain-dependent antimicrobial activity of S. epidermidis
against P. acnes
The results of the antagonism assay were then analysed
from the perspective of the antimicrobial activity of S.
epidermidis. Eleven out of 20 S. epidermidis strains dis-
played varying degrees of antimicrobial activity against
25 P. acnes strains (Table 3). Among the S. epidermidis
strains with an elevated antimicrobial activity, differ-
ences in inhibition zone diameter and appearance were
observed, indicating that the antimicrobial substances
were of different nature (Fig. 1). Most of the S. epidermi-
dis strains displayed small zones of inhibition (2- 4 mm)
against P. acnes and some strains produced opaque
zones of inhibition. Interestingly, one strain, FS1, pro-
duced very large inhibitory zones (>10 mm), but was not
active against all P. acnes strains tested. Another strain,
14.1.R1, was able to inhibit all P. acnes strains, but pro-
duced small zones of inhibition (2-5 mm). No difference
in prevalence and intensity was noted in the antimicro-
bial activity of S. epidermidis strains isolated from nor-
mal and acne-affected skin, respectively (Table 3).
Likewise, the origin of P. acnes strains did not determine
their susceptibility to the antimicrobial activity of S.
epidermidis, since strains isolated from acne lesions and
healthy skin, respectively, were not significantly different
in their susceptibility patterns towards S. epidermidis
(Additional file 4).
Antimicrobial activities of S. epidermidis strains 14.1.R1
and FS1
To further characterize the observed broad antimicrobial
activity of S. epidermidis strain 14.1.R1, the screening was
extended with 29 additional P. acnes strains representing
all phylogroups. All additional P. acnes strains were also
inhibited by this S. epidermidis strain (Additional file 5).
To test whether the antimicrobial activity of S. epidermidis
strain 14.1.R1 was P. acnes-specific, other Gram-positive
and Gram-negative bacteria were also screened. S. epider-
midis strain 14.1.R1 did not have the ability to inhibit any
of the other bacterial species tested, except for a Propioni-
bacterium granulosum strain. This shows that the anti-
microbial activity of strain 14.1.R1 is P. acnes-specific, and
might be active against closely related propionibacteria as
well, but not against species of other genera.
Strain FS1 produced the largest inhibition zones of all
tested S. epidermidis strains. It was particularly active
against P. acnes type II and III strains (inhibition
Table 1 Antimicrobial activity of different phylotypes of P. acnes
against 12 S. epidermidis strains
Phylogroup Antimicrobial activity in %a
I-1a (43 strains) 32 %
I-1b (4 strains) 42 %
I-2 (14 strains) 61 %
III (2 strains) 21 %
II (14 strains) 20 %
aexplanatory example: P. acnes I-1a strains inhibited in average 32 % of the
tested S. epidermidis strains, whereas I-2 strains inhibited in average 61 % of
the tested S. epidermidis strains
Table 2 Origin of P. acnes strains and their antimicrobial activity
against S. epidermidis
Skin status Antimicrobial activity in %
healthy skin (22 strains) 38 %
light acne (17 strains) 34 %
moderate acne (11 strains) 39 %
severe acne (6 strains) 29 %
Table 3 Antimicrobial activity of 20 S. epidermidis strains against
25 P. acnes strains
S. epidermidis strain Isolated from Antimicrobial
activity in %a
14.1.R1 upper back, light acne 100
AU40 healthy alar crease 88
AU21 healthy nares 72
FS1 face, light acne 68
GS3 face, moderate acne 64
AU23 healthy nares 64
AU48 healthy nares 28
AU39 healthy alar crease 12
AU60 healthy nares 8
AS1 alar crease, light acne 8







aListed from most potent to least potent strain, e.g., 100 % refers to an
antimicrobial activity of S. epidermidis against all 25 P. acnes strains
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zone >10 mm). A diffuse, smaller inhibition zone
against most P. acnes type I strains was observed
(data not shown).
Comparative genomics of S. epidermidis highlights core
genome diversity
In order to investigate the genetic basis for the anti-
microbial activity of S. epidermidis against P. acnes,
strains with broad (14.1.R1), medium (FS1, AU21,
AU23) and no (AU24) inhibitory activities were se-
lected and genome sequenced. One strain (AU23) was
sequenced with high quality by PacBio technology
and the three other isolates (FS1, AU21, AU24) were
Illumina-sequenced. The genome sequence of the
strain 14.1.R1 was taken from GenBank (accession
number AGUC00000000; 2,555,725 bp in 131 con-
tigs). The genome of strain FS1 has a similar size
with 2,551,451 bp (in 91 contigs). The genomes of
strains AU21 (2,421,814 bp in 72 contigs) and AU24
(2,429,243 bp in 61 contigs) are considerably smaller
compared to 14.1.R1 and FS1, on average 130 kb.
The genome size of strain AU23 is 2,487,973 bp (in 5
contigs); one contig of 42 kb represents a plasmid.
To assess the phylogenetic distance of the five isolates
and to relate them to other S. epidermidis strains, a
phylogenetic tree was constructed based on the core
genome of 112 S. epidermidis genome sequences
(Fig. 2). The size of the core genome is approximately
1.7 Mb, which is in concordance with previous find-
ings [13]. The tree shows that the S. epidermidis
population is divided into two main clades, with a
large heterogeneity within each clade. The core
genomes of AU21 and AU23 are almost identical, and
they group together in the same clade as strain
AU24. Strain FS1 belongs to the same clade, but is
located in an outlier cluster, indicating increased
phylogenetic distance to strains AU21, AU23 and
AU24. The strain 14.1.R1 is phylogenetically most dis-
tinct and clusters in the second clade. Thus, antimi-
crobially active S. epidermidis strains are scattered in
phylogenetically not closely related clades. This indi-
cates that the inhibitory activity of S. epidermidis
against P. acnes is not part of the core genome, but
is rather encoded in the accessory genome.
The accessory genome encodes diverse fitness functions
including factors involved in interbacterial competition
In order to identify the genomic basis for the antimicro-
bial activity against P. acnes, we focussed on genomic
regions in strains AU21, AU23, FS1 and 14.1.R1 that are
absent in strain AU24, the isolate without inhibitory
activity. Comparative genome analysis revealed that all
Fig. 1 Simultaneous antagonism assay of S. epidermidis against P. acnes. A representative result of a simultaneous antagonism assay is shown.
A large TS agar plate was floated with a suspension of a P. acnes indicator strain, and strains of S. epidermidis were point-inoculated on the agar surface.
Growth inhibition around several of the S. epidermidis colonies is apparent. Diameters of the depicted inhibitory zones ranged from 3 mm to 20 mm.
Arrows point to the individual zones of inhibition, i.e., opaque (O), small (S), medium (M), large (L) zones, or no inhibition zone (N)
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strains comprise several mobile genetic elements that
are only rarely found in other sequenced S. epidermidis
strains, and that confer a variety of fitness functions,
including antibiotic and stress resistance, biofilm forma-
tion, interbacterial competition and, possibly, virulence.
A comprehensive analysis was done for each strain:
AU21 and AU23
Strains AU21 and AU23 had similar moderate anti-
microbial activities against P. acnes, and produced
diffuse inhibitory zones. The accessory genomes of both
strains are largely identical, underlining their close
phylogenetic relationship. The accessory genome of
strains AU21 and AU23 is distributed in six larger re-
gions, that are absent in the chromosome of strain
AU24 (Additional file 6A and Additional file 7A). A
variety of functions can be found. One region (region 1
in Additional file 6A) is rarely found in any other
sequenced S. epidermidis genome; it is a genomic resist-
ance island of possible phage origin, encoding FusB that
confers resistance to the antibiotic fusidic acid. This
island has recently been described in S. epidermidis
strain NTUH-3692 [20]. Another genomic island (region
3) encodes proteins conferring increased tolerance to
divalent metal ions such as zinc, copper and cobalt.
Region 5 encodes an arginine deiminase (ADI) system,
catalyzing the conversion of arginine to ornithine via
citrulline, thereby generating NH3 and ATP. The ADI
system is used by several bacterial species to facilitate
survival in acidic conditions [21]. At least two other
islands (region 2 and 4) encode proteins related to the
bacterial surface, such as teichoic acid modifying en-
zymes and the cell surface proteins SasG and SasC that
are implicated in host interactions and biofilm accumu-
lation [22]. The 42 kb plasmid (region 7) encodes among
others several transport systems, a putative lysine (or
arginine) biosynthesis gene cluster, and proteins protect-
ive against oxidative stress such as glutathione peroxid-
ase/reductase (Additional file 7A).
The shared accessory genome of AU21 and AU23
encodes no known bacteriocin or any other previously
identified antimicrobial system. We conclude that the
inhibitory activity of these strains is conferred either by
an unknown bacteriocin or bacteriocin-like substance, or
by other means, such as the secretion of the fermenta-
tion product succinic acid, which has been shown to
inhibit P. acnes [23]. In this regard, the ADI system
found in AU21 and AU23 might increase self-protection
of succinic acid-producing cells from the adverse effects
of acidification.
FS1
Strain FS1 produced the largest zones of inhibition
against most P. acnes strains. Its genome harbors 10
Fig. 2 Phylogenetic tree of 112 S. epidermidis strains based on the
shared core genome. Phylogenetic analysis the core genome
sequence of approximately 1.7 Mb divides the S. epidermidis
strain population in two distinct clades. The sequenced strains
used in the antagonism assay are highlighted in red
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genomic regions that are absent from strain AU24 and
most other sequenced S. epidermidis strains, including
the three examined strains AU21, AU23 and 14.1.R1
(Additional file 6B and Additional file 7B). Several re-
gions encode phage-related proteins (regions 3, 4, 8 and
partially 10 in Additional file 6B). Region 8 has similarity
to S. aureus superantigen-encoding pathogenicity islands
(SaPIs). These phage-related chromosomal islands are
considered to be phage satellites or parasites [24]. An-
other island (region 6) represents the well-characterized
biofilm operon icaADBC that encodes the polysacchar-
ide intercellular adhesin (PIA) [25]. Two genomic
regions are interesting with regards to antimicrobial ac-
tivity. Region 1 represents a full or partial plasmid, as
judged from the presence of genes encoding plasmid
replication proteins and a toxin-antitoxin system confer-
ring plasmid stabilisation (Additional file 7B). This 42 kb
region harbors an operon encoding a bacteriocin,
belonging to the lactococcin-972 superfamily (Pfam09683),
an immunity protein as well as a putative bacteriocin
export ABC transporter. The other genomic region encod-
ing an antimicrobial substance is a 12 kb cluster located in
region 10. It encodes EpiA, the precursor peptide for the
well-characterized lantibiotic epidermin, as well as
proteins involved in posttranslational modification of
EpiA, including homologs of EpiBCDRP [26]. Epider-
min has been shown to act on several Gram-positive
bacteria, including P. acnes. Interestingly, epiP is
frameshifted in the genome of FS1, resulting in a
truncated protein. EpiP is the precursor-processing
protease that cleaves the 52-aa precursor peptide into
the mature 22-aa bioactive peptide [27]. This raises
doubts about the activity of the epidermin(-like) pep-
tide in strain FS1. Biosynthesis of epidermin is
encoded on a 54 kb plasmid in S. epidermidis strain
Tü3298 [26]. Thus, it is likely that the 12 kb epiA
containing contig (region 10) and the 42 kb plasmid
contig (region 1) together constitute a 54 kb plasmid.
In summary, the antimicrobial activity of strain FS1
likely derives from one or both identified bacteriocins.
14.1.R1
Next, we analysed the genome of S. epidermidis 14.1.R1,
the strain with extraordinary antimicrobial activity
against P. acnes. The genome comparison revealed eight
large genomic islands, some of which are only found in
strain 14.1.R1 (Fig. 3). Signatures of their horizontal
acquisition can be detected in these clusters, such as an
aberrant GC content and/or GC skew, and mobility-
associated functions including replication proteins and
integrases (Fig. 3 and Additional file 7C). Region 1 en-
codes antibiotic resistance determinants (beta-lactamase)
and a recombinase system similar to the Staphylococcal
Cassette Chromosome mec (SCCmec). Region 2 encodes
an alternative secretion system, the accessory Sec sys-
tem (SecA2-SecY2) that is dedicated to the export of
a family of glycosylated serine-rich repeat proteins
[28]. Region 3 constitutes a prophage genome that is
also present in Staphylococcus capitis. Regions 4 and
6 represent phage-related chromosomal islands with
similarity to SaPIs [24]. The SaPI-like region 4 har-
bours the putative virulence gene vapE as previously
noted in the literature [20]. Region 5 harbors a large
gene (4.6 kb) encoding a biofilm-associated protein
(Bap) that has been shown to be important in biofilm
formation independent of the PIA/PNAG exopolysac-
charide [29]. Region 7 is described below in more
detail. Region 8 is composed of 7 different contigs
varying between 3 and 14 kb in size. Some of these
contigs appear to be plasmids. Most S. epidermidis
strains contain plasmids; one to six plasmids are
present in the strains that have been completely
sequenced to date. Strain 14.1.R1 contains most likely
several plasmids. For example, a 14 kb contig
(AGUC01000118) has similarity to S. epidermidis
plasmid SAP110A (NC_013383) that encodes anti-
biotic resistance functions.
S. epidermidis strain 14.1.R1 harbors the ESAT-6 secretion
system
A 27 kb genomic region (region 7, located on contig
AGUC01000069) of strain 14.1.R1 is of particular inter-
est (Additional file 7C). This island is absent in most
sequenced S. epidermidis strains, but a BLASTn analysis
showed partial homology to S. aureus. The 27 kb region
harbors 43 genes (Fig. 4); among them are seven genes
(esxA, esaA, essA, esaB, essB, essC, and esxB) that encode
components of the ‘early secretory antigenic 6 kDa’
(ESAT-6) secretion system (ESS) and ESS-secreted sub-
strates. To our knowledge, this Sec-independent secre-
tion system has so far not been described in any other S.
epidermidis strain. The ESS, with similarity to the type
VII secretion of Mycobacterium tuberculosis, has been
studied in S. aureus, where it was found to be involved
in virulence via the secretion of various factors, includ-
ing EsxA, EsxB, EsaC and EsaD [30–32]. Strikingly, EsxA
was detected in this study in the bioactive supernatant
of S. epidermidis 14.1.R1 by mass spectrometry (see
below), indicating that the ESS is functional and might
contribute to the special antimicrobial phenotype of this
strain. Besides the 12 kb ESS locus, other genes within
this 27 kb region might be functionally linked to the
secretion system. The genes downstream of the ESS
cluster encode several polymorphic toxins with nuclease
domains and associated immunity proteins. It is hypoth-
esized that such nuclease toxins can confer contact-
dependent growth inhibition (see discussion).
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Partial purification and initial characterization of the
bioactive compound from S. epidermidis 14.1.R1
It was noted that the antimicrobial activity of strain
14.1.R1 against P. acnes could be obtained only when S.
epidermidis was grown on agar plates; no significant
antimicrobial activity could be detected when S. epider-
midis was grown in liquid medium. Hence, a partial
purification of the bioactive compound of strain 14.1.R1
was tried using agar plate-grown S. epidermidis. A con-
centrated cell-free supernatant (cCFS) extract was ob-
tained from harvesting 45 agar plates. It was noted that
bioactivity was rapidly lost upon dilution of the cCFS.
Stability of the bioactivity was reduced when storing the
cCFS at 4 °C in non-coated Eppendorf tubes, indicating
Fig. 3 Genome comparison of 17 S. epidermidis strains. Strain 14.1.R1 was used as the reference genome. The four newly sequenced genomes of
strains FS1, AU23, AU21 and AU24 are represented by the four outermost rings. The other 13 genomes were selected based on their position in
the phylogenetic core genome tree, which shows the clustering of strains VCU128, NIHLM023, NIHLM061, VCU118 and VCU129 with strain
14.1.R1 (Fig. 2). Regions of genomic variability (1-8) can be detected (see Additional file 7C for their gene content). The BRIG program
was used to generate the figure
Fig. 4 Genomic locus in S. epidermidis 14.1.R1 encoding an ESAT-6 secretion system and multiple nuclease/immunity protein pairs. In orange,
ESAT-6 secretion system (ESS) and secreted effectors (from right to left: esxA, esaA, essA, esaB, essB, essC, unknown effector, esxB), In red: proteins
with DNA/RNA nuclease domains, possible toxin components; in green, SMI1/KNR4 family (SUKH-1) domain proteins, possible immunity components;
lila, serine protease (NfeD-like protein); in blue, proteins with domains of unknown function (DUF600, DUF1851, DUF4467). PTS, polymorphic toxin
system. See Additional file 7C for the genomic location and annotation
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non-specific adsorption of the bioactive substance to the
vessel walls. Coating of the tubes with Emulphogene®
could prevent the time-dependent loss of activity. Expos-
ure of the cCFS to proteinase K resulted in a complete
loss of inhibitory activity, suggesting that the active sub-
stance is of proteinaceous nature. Antimicrobial activity
was unaffected following exposure to low pH (pH 2) for
2 h with subsequent neutralization. Heat treatment of
the cCFS (60 °C for 10 min) led to complete loss of
inhibitory activity.
Identification of proteins in the bioactive cCFS extract of
S. epidermidis 14.1.R1
In an attempt to identify the antimicrobial compound
produced by S. epidermidis 14.1.R1, the cCFS containing
the bioactivity against P. acnes was analysed by MS. The
cCFS extract was separated in different concentrations
by SDS-PAGE and visible bands were subject to MS ana-
lysis (Additional file 8). Two proteins, the phenol soluble
modulin (PSM) β1 (MW: 4639 Da) and PSMβ2 (MW:
4644 Da) were identified in one band. Homologs of
PSMβ1 and PSMβ2 were found in the genome of strain
14.1.R1 (Additional file 9). The non-cytolytic PSMβ pro-
teins have been previously investigated; they are associ-
ated with promotion of biofilm structuring, maturation
and detachment in vitro [33, 34]. It is unlikely that the
non-cytolytic PSMβ proteins are responsible for the anti-
microbial activity of strain 14.1.R1, since these proteins
are not unique to strain 14.1.R1, but present in many S.
epidermidis strains, including the non-inhibiting strain
AU24. Moreover, the PSMβ proteins are heat-resistant
[35], but we showed that the bioactive protein of strain
14.1.R1 is heat-labile.
A second band of the SDS-PAGE gel was identified as
EsxA (HMPREF9956_2246) (Additional file 10). This
protein is encoded in the ESS island described above,
and is a known effector protein secreted by the ESS. The
function of this protein in S. epidermidis needs to be
explored in the future.
Another protein band was identified as a protein simi-
lar to DNA-binding protein HU of S. aureus strain
Mu50 (HMPREF9956_1196) (data not shown). This
histone-like protein belongs to the nucleoid-associated
proteins and contributes to chromosomal compaction
and maintenance of negative supercoiling.
Taken together, these data indicate that S. epidermidis
strain 14.1.R1 secretes putative virulence factors such as
PSMs and EsxA. The fact that EsxA was detected indi-
cates that the ESAT-6 secretion system is functional in
S. epidermidis 14.1.R1.
Discussion
Interspecies competition is a common phenomenon
among members of the (human) microbiota; it can be
conferred by several means. Prevalent are secreted anti-
microbial substances of the bacteriocin family that can
kill competing bacteria with different mechanisms, for ex-
ample by pore-forming, nuclease, or cell wall synthesis-
interfering activities. In addition, primary or secondary
metabolites also impact on the microenvironment of the
producing cell; this can result in the inhibition of compet-
ing bacteria in the close vicinity.
This study examined the antimicrobial action of P.
acnes against S. epidermidis and vice versa as deter-
mined by an in vitro simultaneous antagonism assay. In
agreement with previous findings, bacterial antagonism
between P. acnes and S. epidermidis is a common
phenomenon [23, 36]. Our study revealed a higher fre-
quency of antimicrobial activity among P. acnes strains
belonging to the I-2 phylogroup as compared with other
phylogroups of P. acnes against S. epidermidis. A likely
possibility is the presence and secretion of a bacteriocin
or bacteriocin-like substance specific to phylogroup I-2.
A genomic comparison previously identified some phy-
logroup I-2-specific genes [18, 19]. Among these, a thio-
peptide biosynthesis gene cluster located in a genomic
island is present in all genomes of I-2 strains. Transcrip-
tome analyses of P. acnes have highlighted the activity of
this genomic island in the I-2 phylogroup of P. acnes
[18]. Two thiopeptide precursor peptides are encoded in
the P. acnes thiopeptide gene cluster; one precursor
possesses the 16-aa structural peptide of berninamycin
A from Streptomyces bernensis [37]. We therefore
assume that the P. acnes thiopeptide has structural simi-
larity or identity to berninamycin A. Thiopeptides such
as berninamycins have been isolated from soil-derived
bacteria of the Streptomyces genus and from marine
sources, and are peptides with an antimicrobial potential
that are potent inhibitors of protein synthesis in Gram-
positive bacteria [38, 39]. Thus, we hypothesize that a
thiopeptide produced by P. acnes type I-2 strains could
be responsible for the more frequent antimicrobial activ-
ity against S. epidermidis. Future research needs to be
done to confirm this hypothesis.
With regard to the antimicrobial activity of S. epider-
midis against P. acnes, the current study revealed a
strain-dependent pattern of antimicrobial activity among
S. epidermidis. In agreement with the study of Holland
et al. [36], we found no difference in the antimicrobial
susceptibility among P. acnes isolates from healthy or
acne-affected individuals. This might mean that suscep-
tibility/resistance of P. acnes towards the antimicrobial
activities of S. epidermidis is not important in the acne
pathogenesis.
Our study showed a large variation of the antimicro-
bial activity among S. epidermidis strains against P.
acnes. Among the inhibitory strains, the nature and size
of inhibition zones varied, indicating that different
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antimicrobial mechanisms are at play. Comparative gen-
ome analyses revealed that there was no strong phylo-
genetic relatedness between inhibitory S. epidermidis
strains. This indicates that the antimicrobial activity is
not encoded on the core genome, but rather encoded on
mobile genetic elements (MGEs) that are exchanged
through horizontal gene transfer. Accessory traits, such
as the ability to produce antimicrobial substances, have
often been found to be encoded on MGEs in staphylo-
cocci [40–42].
Four strains with no, medium or broad antimicrobial
activities were sequenced in order to determine the gen-
omic basis of their respective phenotypes. Based on the
sequence data different possible mechanisms conferring
antimicrobial activity were identified.
1. For strains AU21 and AU23 no known bacteriocin
gene was found to be encoded in the accessory
genome. It is possible that these strains employ
an unknown bacteriocin or an entirely novel
mechanism. Alternatively, the production of
metabolic products could have anti-P. acnes
effects. A candidate is succinic acid that has
been identified to be produced by S. epidermidis
during fermentation [23]. This acid is able to
kill P. acnes by lowering its intracellular pH.
The producer strain needs to develop a
self-protective mechanism against acidification.
Interestingly, AU21 and AU23 carry an arginine
deiminase (ADI) system that can confer such
protection via the production of NH4. The ADI
system has been shown to be crucial for resistance
to acid stress in certain S. epidermidis strains [43].
The involvement of a metabolite such as succinic
acid could also explain the diffuse nature of the
inhibitory zone, which might result from incomplete
lysis of P. acnes.
2. The strain FS1 produced large inhibition zones.
Its genome contains two gene clusters encoding
bactericoins; both clusters are likely to be encoded
on a plasmid of 54 kb. One bacteriocin is of the
lactococcin-972 superfamily and has not previously
been studied to our knowledge. It is 130 aa in size
and harbors an N-terminal signal peptide of 25 aa,
indicative of Sec-dependent export. A putative
immunity protein with transmembrane helices and
a transporter are encoded immediately down-
stream. The second bacteriocin is a lantibiotic.
The precursor peptide is identical to epidermin,
a well-characterized lantibiotic of S. epidermidis
[26]. Epidermin and the closely related gallidermin
act on the cytoplasmic membrane of Gram-
positive bacteria. Gallidermin was successfully
tested in a topical formulation on rat skin
showing antibacterial activity against P. acnes
and S. aureus [44]. Due to the detected frameshift
mutation of epiP in strain FS1, it has to be
investigated in the future if the epidermin precursor
peptide is not cleaved or processed differently in
strain FS1.
3. Our study further revealed that the S. epidermidis
strain 14.1.R1 had a broad inhibitory activity; it was
the only tested S. epidermidis strain that inhibited
all tested P. acnes strains. By a whole genome
comparison approach, we searched for the
underlying gene(s) responsible for the exceptional
phenotype of S. epidermidis 14.1.R1. One genomic
island was of special interest, the island was neither
found in strain AU24, nor in most other genomes
of sequenced S. epidermidis strains. Encoded on this
island is a specialized ESAT-6 secretion system
(ESS), which is homologous to the type VII secretion
system of M. tuberculosis [30, 45]. This system
in mycobacteria is required for full virulence as
it has roles in the survival of mycobacteria in
macrophages, granuloma formation, induction of
apoptosis and autophagy, phagosomal rupture, and
host cell lysis [30, 45–48]. The ESS has also been
described in other Gram-positive bacteria, including
S. aureus [31, 32, 45], but it has not yet been described
in S. epidermidis. ESS-secreted effectors, belonging
to the WXG100 family of proteins, whereof ESAT-6
and CFP-10 from M. tuberculosis are the founding
members, have been identified in S. aureus, designated
EsxA and EsxB for ESAT-6 extracellular protein A
and B, respectively [31, 49–52]. No clear biological
function has been attributed to the ESS effector
proteins in S. aureus to date, but mutants that failed
to secrete EsxA and EsxB displayed defects in abscess
formation in mice, suggesting that these proteins are
important during staphylococcal disease [31]. A recent
study showed that EsxA interferes with host cell
apoptotic pathways and, together with EsxB, mediates
the release of intracellular S. aureus from the host cell
[52]. The ESS is most likely functional in strain S.
epidermidis 14.1.R1 as we could detect EsxA in the
cell-free supernatant. However, it is unlikely that EsxA
is responsible for the exceptional antimicrobial activity
of S. epidermidis 14.1.R1 against P. acnes, since EsxA
homologs have not been described as antimicrobial
but rather as host cell-interacting factors involved in
persistence and spread of the bacterium in the host.
[31, 51, 52] The genomic island encoding the ESS has
another interesting feature that could be linked to,
or responsible for, the antimicrobial activity of
strain 14.1.R1. Bioinformatics analysis revealed
that the island contains other possible ESS
effectors: The protein encoded downstream of
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esxB has an N-terminal LXG domain, a possible
recognition site for a type VII secretion system [53];
its C-terminus encodes a predicted ribonuclease
domain, which is a toxin component of the YeeF-
YezG toxin-antitoxin module. In fact, this protein
represents a polymorphic toxin; such toxins have
recently been discovered to mediate interbacterial
competition [53–55]. Moreover, many of the 34 genes
downstream of ESS encode other toxins and
immunity proteins of the SUKH superfamily. These
toxin-immunity protein pairs are orphan modules,
encoding alternate toxin domains and their cognate
immunity proteins; such orphan modules have been
found in many bacteria [53–56]. The toxin domains
include DNA/RNA non-specific endonuclease
(pfam13930); nuclease of the HNH/ENDO VII
superfamily (pfam14414); toxin 43 superfamily
(pfam15604) and serine protease (NfeD-like
protein). Some polymorphic toxin systems are
involved in contact-dependent growth inhibition (CDI)
[56, 57]. CDI has been reported in proteobacteria;
direct contact with the target cell is required to deliver
nuclease toxins into target cells. Taken together, we
hypothesize that a type VII-like secretion system in
S. epidermidis 14.1.R1 is able to deliver polymorphic
toxins directly onto or into target bacteria resulting
in CDI. This could be a possible explanation of the
broad antimicrobial phenotype of strain 14.1.R1
against P. acnes, with the rather small inhibitory zones
produced by 14.1.R1. It would also explain why we
were unable to purify the antimicrobial substance and
why the anti-P. acnes activity was only observed when
S. epidermidis 14.1.R1 was grown on agar plates.
Further studies are required to assess the in vivo rele-
vance of the anti-P. acnes activity exerted by many S.
epidermidis strains. The method used in this study is an
in vitro antagonism assay. The detectable inhibitory ac-
tivity is dependent on growth conditions such as the
medium composition and the applied incubation condi-
tions (e.g., oxygen levels). Therefore, it is not clear to
what degree the inhibition phenomena obtained on agar
medium reflect the in vivo settings on human skin. It
further needs to be clarified if the antimicrobial activity
results in a competitive advantage of the producing
strain in vivo and how this impacts on the skin
ecosystem.
Conclusions
This study examined antagonistic interactions of two
prominent members of the skin microbiota, P. acnes and
S. epidermidis. The study showed a variety of clade- and
even strain-specific inhibitory activities. Genome se-
quencing of selected S. epidermidis isolates highlighted
the heterogeneity of this species, and the presence of
multiple genomic islands. Accessory genome analyses
identified several possible inhibitory mechanisms, in-
cluding the secretion of acidic fermentation products
and the respective self-protection via ADI, the produc-
tion of bacteriocins such as epidermin, and the employ-
ment of a type VII-like secretion system (ESS) that
might deliver polymorphic toxins on or into the target
cell. The functionality of this system in S. epidermidis is
likely, as judged from the identification of an ESS
effector in the culture supernatant.
As a possible application, it could be envisaged that
the diverse anti-P. acnes activity of S. epidermidis could
be exploited, for example as a probiotic treatment ap-




S. epidermidis and P. acnes strains originating from
healthy and acne-affected individuals were obtained by
skin swabs using cotton sticks. The strains were previ-
ously collected by Lomholt and Killian [12]. All strains
were previously identified by 16S rRNA amplicon
sequencing, and, for the P. acnes isolates, further typed
by multi-locus sequence typing (MLST) [12]. Detailed
information about the origin and the phylotypes of the
strains used in this study is given in Additional file 1
and Additional file 2.
Bacteria were cultivated on 5 % sheep blood agar
medium for one (S. epidermidis) or three (P. acnes)
days. S. epidermidis was cultivated at 37 °C aerobically,
supplemented with 5 % CO2. P. acnes was cultivated at
37 °C in an anaerobic chamber, in an atmosphere of
80 % N2, 10 % CO2 and 10 % H2.
Agar plate antagonism assay to screen for antimicrobial
activity
P. acnes strains were individually screened for antimicro-
bial activity against S. epidermidis indicator strains. The
screening procedure was carried out as a simultaneous
antagonism assay, as described by Tagg and Bannister,
with slight modifications [58]. In brief, the screenings
were carried out on large Trypticase Soy (TS) agar plates
(14 cm diameter) by the following procedure: 150 μl
liquid TS broth cultures of individual P. acnes strains
was aliquoted into wells of a flat-bottom 96-well microti-
ter plate. TS agar plates were floated with a lawn of the
individual S. epidermidis (suspended in 0.85 % NaCl) indi-
cator strains. The concentrations of the indicator strain
suspensions were standardized by comparison to a 0.5
McFarland standard (150 × 106 CFU/ml, OD = 0.125).
The plates were allowed to dry in a laminar flow bench
for 15 min. The P. acnes strains were then simultaneously
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point-inoculated with an in-house developed multi-
inoculator device onto the surface of the TS agar plates.
The plates were incubated at 37 °C for 72 h, in an anaer-
obic chamber, in an atmosphere of 80 % N2, 10 % CO2
and 10 % H2, and examined for zones of growth
inhibition.
The same approach was used to screen S. epidermidis
strains for their antimicrobial activity against P. acnes in-
dicator strains. TS agar plates were floated with a lawn
of the individual P. acnes indicator strains. 20 S. epider-
midis strains were simultaneously point-inoculated onto
the surface of the TS agar plates and the plates were
incubated at 37 °C for 72 h in an anaerobic chamber. In
addition, plates were incubated in microaerophilic con-
ditions, using the GasPak system (Oxoid, AnaeroJar)
with CampyGen sachets. Each antagonism assay was
carried out in triplicates.
Building a S. epidermidis core genome phylogenetic tree
Genome sequences of 112 S. epidermidis strains were
used to build a phylogenetic tree based on all shared se-
quences (i.e., the core genome of the species). Genomes
were downloaded from NCBI Genome and WGS data-
bases, with the exception of strains AU21, AU23, AU24
and FS1 that were sequenced for this study. The core
genome was identified by slicing the genome sequence
of strain 14.1.R1 into fragments of 200 bp which were
used as query sequences in BLASTn (BLAST+) [59] to
extract homologous sequences from the other 110
genomes. Default parameters of BLASTn were used
together with a 65 % cut-off on coverage. Homologous
sequences of each fragment were aligned using Muscle
[60] and subsequently all fragments were concatenated
into one sequence per strain using a python script. The
core genome phylogenetic tree was built in Mega v6 [61]
using the minimal-evolution algorithm with pair-wise
deletion and 100 bootstrap replications. A total of
139,881 single nucleotide polymorphisms were found.
Genome sequencing
Genomic DNA from S. epidermidis strains AU21, AU23,
AU24 and FS1 was isolated using the MasterPure Gram-
positive DNA Purification Kit (EpiCentre MGP04100)
according to the manufacturer’s instructions. The purity
and quality of the gDNA were assessed on a 1 % agarose
gel and with a nanodrop apparatus. For strains AU21,
AU24 and FS1, library preparation and Illumina sequen-
cing were carried out at the Göttingen Genomics
Laboratory, Germany. Sequences were trimmed with
Trimmomatic 0.32 (http://www.usadellab.org/cms/?page=
trimmomatic) and assembled with SPAdes 3.1.1 (http://
bioinf.spbau.ru/en/spades), resulting in 2,421,814 bp in 72
contigs (AU21), 2,429,243 bp in 61 contigs (AU24), and
2,551,451 bp in 91 contigs (FS1), respectively. The GenBank
accession numbers of the draft genome sequences are
LNUN00000000 (AU21), LNSW00000000 (AU24) and
LOAT00000000 (FS1).
The genome of S. epidermidis AU23 was sequenced
on a PacBio RS I sequencing instrument using an 10 kb
insert library (GATC Biotech AG, Germany), resulting in
a total of 66,762 post-filtered continuous long reads with
an average length of 3,687 bp. A sequence coverage of
approximately 81-fold was obtained after sequence read
assembly, that resulted in a genome size of 2,487,973 bp
split into 5 contigs. The GenBank accession number of
the draft genome sequence of strain AU23 is
LNUS00000000.
Gene prediction, annotation and comparative genome
analysis
For S. epidermidis strains AU21, AU23, AU24, and FS1
open reading frames (ORFs) and tRNAs were identified
and annotated using the RAST server [62]. Additional
manual annotation of ORFs of interest was performed
on the basis of homology searches with the public non-
redundant (nr) database using BLASTp. Domain search
was done using PFAM (http://pfam.xfam.org/). For com-
parative genome analysis, the program BRIG was used
[63]. The following genomes of S. epidermidis were
taken from GenBank to build a BRIG genome compari-
son: 14.1.R1 [BioProject: PRJNA64683], VCU128 [BioPro-
ject: PRJNA53771], VCU118 [BioProject: PRJNA53755],
VCU129 [BioProject: PRJNA53773], VCU071 [BioProject:
PRJNA53733], VCU105 [BioProject: PRJNA53739], VCU
127 [BioProject: PRJNA53769], RP62A [BioProject: PRJ
NA64], NIHLM023 [BioProject: PRJNA62371], NIH
LM061 [BioProject: PRJNA62355], NIHLM067 [BioPro-
ject: PRJNA62353], FRI909 [BioProject: PRJNA48603],
ATCC12228 [BioProject: PRJNA279].
Partial purification of bioactive fraction from S.
epidermidis 14.1.R1
S. epidermidis strain 14.1.R1 was cultivated on 45 TS
agar plates containing 0.1 % (w/v) skim milk at 37 °C in
an aerobic atmosphere supplemented with 5 % CO2 for
24 h. Bacteria were harvested from all plates and sus-
pended in 225 ml 0.9 % NaCl solution. The bacteria
were then removed by centrifugation at 5000 g for
30 min at room temperature, followed by sterilization of
the supernatant using 0.22 μm filter disks (Sarstedt). The
cell-free supernatant (CFS) was concentrated 75-fold by
centrifugal ultrafiltration on a Centriprep® centrifugal filter
unit (Millipore) at 3000 g at 4 °C. The protein content in
the concentrated CFS (cCFS) was measured by UV
absorption at 280 nm. To assay for the potency of cCFS,
multiple dilutions were made and tested for bioactivity
against a sensitive P. acnes indicator strain by the spot-on-
lawn assay; a volume of 10 μl cCFS was spotted onto the
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centre of a pre-dried 5 % sheep blood agar plate seeded
with a suspension of a P. acnes indicator strain (0.5
McFarland standard: 150 × 106 CFU/ml, OD550nm =
0.125). The plates were incubated at 37 °C in an anaerobic
chamber, in an atmosphere of 80 % N2, 10 % CO2 and
10 % H2, for 48 h. A clear zone of growth inhibition
surrounding the spotted samples indicated antimicrobial
activity.
Effect of proteinase K, pH, heat treatment and storage on
antimicrobial activity
The sensitivity of the cCFS to proteolytic activity was
tested, employing a 2 h treatment with proteinase K at
37 °C at a final concentration of 10 mg/ml. After incuba-
tion, the cCFS was assayed for residual activity. In order
to determine the effect on pH on bioactivity, the pH of
the cCFS was adjusted to pH 2 using 1 M HCl and incu-
bated at RT for 2 h, before neutralizing. The cCFS was
subsequently assayed for residual activity. To determine
the thermal stability, the cCFS was heated at 60 and 80 °C
for 10, 30 or 60 min, respectively, after which each sample
was assayed for residual activity. The cCFS was stored
at -20 °C and 4 °C. At different time intervals, between
24 h and 120 days, the cCFS was assayed for residual ac-
tivity. Containers used in the following experiments were
coated with Emulphogene® (Polyoxyethylene 10 Tridecyl
Ether, Sigma-Aldrich) in order to prevent binding of the
active substance to the container surface.
Gel electrophoresis and mass spectrometry
The cCFS was subjected to protein identification. Since
most antimicrobial substances are low molecular weight
(LMW) compounds we focussed on the analysis of
LMW proteins, using tricine-sodium dodecyl sulphate-
polyacrylamide gel electrophoresis (tricine-SDS-PAGE)
[64]. Polyacrylamide concentration in the separating gel
was 18 %. Electrophoresis was conducted at a constant
voltage of 50 V for 30 min, followed by 120 V for 4 h. A
polypeptide SDS-PAGE molecular weight standard (Bio-
Rad) with sizes ranging from 1.06 to 26.6 kDa was
included. After electrophoresis the gel was silver stained
and bands were selected for Matrix-Assisted Laser De-
sorption/Ionization Quadrupole Time-Of-Flight (MALDI-
Q-TOF) Mass Spectrometry (MS). Individual protein
bands were excised from the gel, destained and subjected
to in-gel tryptic digestion as described previously [65].
The extracted peptides were desalted using C18 Stage Tips
(Proxeon, Thermo Scientific) and the adsorbed peptides
were eluted directly onto a Bruker Autoflex MSP 96 Stain-
less Steel Target Plate using 1 μl MALDI-matrix solution
(2 mg/mL α-cyano-4-hydroxy-cinnamic acid (CHCA),
750 μl acetonitrile, 248 μl dH2O, 2 μl trifluoroacetic acid).
The solvent was allowed to evaporate leaving matrix crys-
tals in which the tryptic peptides were embedded. The
mass-to-charge (m/z) ratios of eluted peptides were ana-
lysed on a MALDI-Q-TOF Mass Spectrometer (Micro-
mass Q-Tof Ultima Global, Walters). Fibrinopeptide B
(MW: 1570.6 Da) was used as an internal standard for all
obtained MS data. All generated MS and MS/MS data
were processed using the Mascot software [66]
(www.matrixscience.com). For peptide mass fingerprinting
(PMF), mass spectra were acquired in the positive-ion
mode over the range 700-3500m/z. The search parame-
ters allowed for variable modifications of methionine
oxidation and fixed modifications of cysteine propio-
namide adduct. There was a peptide mass tolerance
of 1.2 Da, and a single missed tryptic cleavage was
allowed in the search. The generated MS/MS data
were examined using the MS/MS Ion Search option
in Mascot, with a fragment mass tolerance of 0.6 Da,
and allowance of 1 missed cleavage. Proteins were
identified via database queries with the search engine
Mascot in three databases (NCBI-nr, Swiss-Prot and Mass
Spectrometry Protein Sequence Database (MSDB)). The
MS data were also searched directly against the proteome
of S. epidermidis 14.1.R1. The probability score calculated
by the software was used as the criterion for correct iden-
tification [66].
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LOAT00000000 (FS1). Other supporting data are in-
cluded as Additional files.
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based on their position in the phylogenetic core genome tree (Fig. 2).
Regions of genomic variability (1-7) can be detected (see Additional file
7A for their gene content). The BRIG program was used to generate the
figure. B. Genome comparison of 17 S. epidermidis strains with strain FS1
as reference. Newly sequenced genomes were included (AU21, AU23,
AU24). The other 13 genomes were selected based on their position
in the phylogenetic core genome tree (Fig. 2). Regions of genomic
variability can be detected (see Additional file 7B for their gene content).
The BRIG program was used to generate the figure. (DOCX 1185 kb)
Additional file 7: A: Seven genomic islands in strain S. epidermidis
AU23. B: Ten genomic islands in strain S. epidermidis FS1. C: Eight
genomic islands in strain S. epidermidis 14.1.R1. (XLSX 331 kb)
Additional file 8: SDS-PAGE analysis of concentrated cell-free
supernatant (cCFS) of S. epidermidis 14.1.R1. Different concentrations
of the S. epidermidis 14.1.R1 cCFS separated on an 18 % polyacrylamide
gel and stained with the silver stain method. Lane 1: broad range molecular
weight standard. Lanes 2–6: different concentrations of S. epidermidis 14.1.R1
cCFS. The gel bands that were analyzed with MALDI-TOF MS are marked
A-C. Proteins were identified using Mascot Search of MS/MS data from the
peptide digest with databases NCBI-nr, MSDB, and Swiss-Prot (and
using the 14.1.R1 genome): A, HMPREF9956_2246 (EsxA) (MW: 11015
Da); B, HMPREF9956_1196 (DNA-binding protein HU (MW: 9626 Da);
C, HMPREF9956_0860 and HMPREF9956_0861 (PSMβ1a/1b) (MW: 4639
Da)/HMPREF9956_0859 (PSMβ2) (MW: 4644 Da). (DOCX 368 kb)
Additional file 9: A. Amino acid sequences of the PSMβ-proteins
from S. epidermidis 14.1.R1. The sequence shown in bold red represents
the sequence coverage by MS analysis. The sequence coverage was 70 %
and 40 % for PSMβ2 and PSMβ1a/1b, respectively. B. The psmβ operon
is composed of four genes in the S. epidermidis strain 14.1.R1. The two
peptides PSMβ1a (HMPREF9956_0861), and PSMβ1b (HMPREF9956_0860)
are identical on protein level; on DNA level there are 3 single nucleotide
polymorphisms. (DOCX 26 kb)
Additional file 10: Amino acid sequence alignment of EsxA from
S. epidermidis 14.1.R1, S. aureus M0733 and M. tuberculosis H37Rv.
The Trp-Xaa-Gly (WXG) motif, a signature sequence of ESAT-6-like proteins,
is marked with three asterisks. The EsxA protein is structurally organized as
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between the two α-helices. (DOCX 82 kb)
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